Valutrades Shareholders Inject Another £1.6M as Fresh Capital

The existing shareholders of London-based Valutrades Limited, which operates as an FX and CFDs broker, have injected £1.6 million (US$2.1 million) into the company by allocating fresh shares.

A Move after a Rough Year

According to the latest Companies House filing, the capital injection came from two share allotments, one for £825,000 and the other for £775,000. The fresh allotment has increased the company’s total share capital to £10.82 million.

Finance Magnates reached out to Valutrades for details on the fresh capital injection but has not received any response as of press time.

Graeme Watkins, CEO at Valutrades

The Valutrades brand operates under two licenses, one from the United Kingdom’s Financial Conduct Authority and the other from the regulator in the Seychelles. The offerings under both entities are more or less the same: trading services with margin forex and contracts for differences of other asset classes.

The Valutrades website is available in five languages: English, Spanish, Portuguese, Mandarin, and Japanese, indicating that it has an extensive global clientele.

Multiple Cash Injections

Interestingly, the latest capital injection came only four months after the Valutrades shareholders injected £1 million into the company.

Another £1 million was injected last October by existing shareholders, led by Anil Bahirwani, the Founder of Valutrades and a couple of other financial services companies. Aman Lakhiani, an existing investor, and Graeme Watkins, who has been running the broker since 2015 as the CEO, continue to hold stakes in the brokerage. Those proceeds went towards the brokerage’s rebranding.

Finance Magnates recently reported that Valutrades’s annual revenue in 2023 plummeted by almost 80 percent to £1.5 million. The company further reported a net loss of nearly £4 million. In the Companies House filing, the broker cited that “2023 was a challenging year” due to “market volatility confined to large ranges,” which resulted in traders shifting to products related to equities.

The existing shareholders of London-based Valutrades Limited, which operates as an FX and CFDs broker, have injected £1.6 million (US$2.1 million) into the company by allocating fresh shares.

A Move after a Rough Year

According to the latest Companies House filing, the capital injection came from two share allotments, one for £825,000 and the other for £775,000. The fresh allotment has increased the company’s total share capital to £10.82 million.

Finance Magnates reached out to Valutrades for details on the fresh capital injection but has not received any response as of press time.

Graeme Watkins, CEO at Valutrades

The Valutrades brand operates under two licenses, one from the United Kingdom’s Financial Conduct Authority and the other from the regulator in the Seychelles. The offerings under both entities are more or less the same: trading services with margin forex and contracts for differences of other asset classes.

The Valutrades website is available in five languages: English, Spanish, Portuguese, Mandarin, and Japanese, indicating that it has an extensive global clientele.

Multiple Cash Injections

Interestingly, the latest capital injection came only four months after the Valutrades shareholders injected £1 million into the company.

Another £1 million was injected last October by existing shareholders, led by Anil Bahirwani, the Founder of Valutrades and a couple of other financial services companies. Aman Lakhiani, an existing investor, and Graeme Watkins, who has been running the broker since 2015 as the CEO, continue to hold stakes in the brokerage. Those proceeds went towards the brokerage’s rebranding.

Finance Magnates recently reported that Valutrades’s annual revenue in 2023 plummeted by almost 80 percent to £1.5 million. The company further reported a net loss of nearly £4 million. In the Companies House filing, the broker cited that “2023 was a challenging year” due to “market volatility confined to large ranges,” which resulted in traders shifting to products related to equities.

This post is originally published on FINANCEMAGNATES.

  • Related Posts

    Weekly Recap: eToro Launches 24/5 Trading for Top 100 US Stocks, AETOS Surrenders FCA License

    eToro opens 24/5 trading on the top 100 US stocks In this week’s roundup of key industry developments, eToro, the publicly listed Israeli fintech firm, launched 24/5 trading for 100…

    Interactive Brokers’ Trading Activity Jumps 27% as Client Assets Surge

    Interactive Brokers Group reported a 27% year-on-year increase in daily trading activity in July, alongside sharp gains in client equity, account numbers, and margin lending. The brokerage said Daily Average…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    August Holidays and Forex Impact: How Holidays Affect Trading?

    • August 2, 2025
    August Holidays and Forex Impact: How Holidays Affect Trading?

    What Are the Main Industrial Uses of Silver in 2025?

    • August 2, 2025
    What Are the Main Industrial Uses of Silver in 2025?

    Difference Between Technical and Fundamental Analysis in Forex

    • August 2, 2025
    Difference Between Technical and Fundamental Analysis in Forex

    Weekly Recap: eToro Launches 24/5 Trading for Top 100 US Stocks, AETOS Surrenders FCA License

    • August 2, 2025
    Weekly Recap: eToro Launches 24/5 Trading for Top 100 US Stocks, AETOS Surrenders FCA License